Asia Knowledge Associates is organising a two-day conclave and exhibition on stem cell therapy named 'India stem cell conclave and India stem cell exhibition 2010'. The conclave and exhibition will be held on October 23 and 24 at Hotel Hyatt Regency, Mumbai. The conclave shall focus on dealing with the challenges faced by the stem cell industry.
According to Prasanna Armugam, chief executive officer of Asia Knowledge Associates, this conclave has been organised as a two-day program of the most cutting-edge content in commercial stem cell use, where industry experts will converge to debate and discuss how to overcome the challenges faced by the stem cell industry today, which can also open opportunities and business development for tomorrow. This conclave will be the premium meeting-ground for industry experts, investors, practitioners, and analysts.
The exhibition has been organised with the sole purpose of creating stem cell awareness that is most required in India today, as most people are not even aware that an alternate treatment in stem cell exists. The event aims to create a movement for stem cell in India by reaching out directly to the citizens of India who matter the most and hold the key to the development of this industry.
Speaking at the event, Arnoud Van Tulder, chief executive officer, Cryo -Save Group said, “Cryo-Save is privileged to be part of India stem cell conclave and exhibition 2010 which is the flagship event uniting the stem cell community by bringing together scientists, patients, advocates, business people, investors, educators, ethicists, policy makers, government representatives, and others to network and learn from each other.”
Chaitanya Purandare, chairman and managing director, StemOne Biologicals added, “This conclave aims to address and resolve all issues that surround the effectiveness of stem cell therapy. Continued research will herald new treatments. One might have overlooked the benefits that this therapy brings to the table for those suffering from serious diseases. Now the time has come to confirm the successful endeavors of stem cell therapies. This conclave and exhibition is an effort to provide a ray of hope for hopeless patients.”
Eminent panelists who would share their insights on various issues at this conclave are Dr V M Katoch, secretary, department of health research and director general, Indian Council of Medical Research; Arnoud Van Tulder, Group CEO, Cryo-Save Netherlands; Dr Praful Pawar, CEO, Apollo Hospitals; Dr Sheikh Tamir Rashid, Stem cells and regenerative medicine, University of Cambridge; and Dr Johan Jakobsson, head of the research group at the department of experimental medical science, Lund University Sweeden among others.